Top

Reactions Weekly

Published in:

01-04-2015 | Case report

Dexpanthenol/ofloxacin

Corneal calcification: case report

Published in: Reactions Weekly | Issue 1/2015

Excerpt

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* requires intervention to prevent permanent impairment or damage

…

Gorsch IC, et al. Cross-linking and neurodermitis: prolonged re-epithelisation with severe corneal vascularisation after cross-linking in a patient with neurodermitis and keratoconus Klinische Monatsblatter Fur Augenheilkunde 231: 636-9, No. 6, Jun 2014. Available from: URL: http://doi.org/10.1055/s-0034-1368374 [German; summarised from a translation] - GermanyCrossRefPubMed

Title: Dexpanthenol/ofloxacin
Corneal calcification: case report
Publication date: 01-04-2015
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-9181-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dexpanthenol/ofloxacin

Corneal calcification: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Rotavirus vaccine

Caspofungin/micafungin

Simvastatin overdose

Hydrochlorothiazide/lisinopril

Dasatinib/imatinib/interferon-α/nilotinib

Imatinib